Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 401–500 of 1,000
Ehmke, N., Parvaneh, N., Krawitz, P. M., Ashrafi, M. R., Karimi, P., Mehdizadeh, M., Krüger, U., Hecht, J., Mundlos, S., & Robinson, P. N. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36772 · Cited by 40
“…been linked to cardiomyopathy, myopathy, neurodegeneration, immune dysfunction, pigmentary defects, oncogenesis, anddisturbed embryonic development [Nishino et al., 2000; Fimia et al., 2007; Nakai et al., 2007; Di Bartolomeo et al., 2010; Taneike et al., 2010; Levine et al., 2011; Choi et al.,…”
BackgroundMyocardial glycogen dynamics: New perspectives on disease mechanisms
Chandramouli, C., Varma, U., Stevens, E. M., Xiao, R., Stapleton, D., Mellor, K. M., & Delbridge, L. M. D. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12370 · Cited by 40
Banduseela, V. C., Chen, Y., Kultima, H. G., Norman, H. S., Aare, S., Radell, P. J., Eriksson, L. I., Hoffman, E. P., & Larsson, L. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2012 · Cited by 40
Maruyama, R., Goto, K., Takemura, G., Ono, K., Nagao, K., Horie, T., Tsujimoto, A., Kanamori, H., Miyata, S., Ushikoshi, H., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91449.2007 · Cited by 40
“The use of leupeptin may mimic the pathophysiological conditions of Danon’s disease (18), and we actually observed the accumulation of gigantic autophagolysosomes containing undigested organelles in ARVCs treated with leupeptin.”
BackgroundImpaired Glucose Tolerance in a Mouse Model of Sidt2 Deficiency
Gao, J., Gu, X., Mahuran, D. J., Wang, Z., & Zhang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066139 · Cited by 40
Pathways of myocyte death: implications for development of clinical laboratory biomarkers
Kostin, S. (2005) · Advances in clinical chemistry · doi:10.1016/s0065-2423(05)40002-5 · Cited by 40
Cooperation between proteolytic systems in cardiomyocyte recycling
Yamaguchi, O., Taneike, M., & Otsu, K. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs236 · Cited by 39
Lysosomal Abnormalities in Cardiovascular Disease
Chi, C., Riching, A. S., & Song, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030811 · Cited by 40
“Numerous cardiovascular diseases exhibit defects in autophagy, including Danon disease [29].”
BackgroundClinical features of Danon disease and insights gained from LAMP-2 deficiency models
Zhai, Y., Miao, J., Peng, Y., Wang, Y., Dong, J., & Zhao, X. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.10.012 · Cited by 39
From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities
Mächtel, R., Boros, F. A., Dobert, J. P., Arnold, P., & Zunke, F. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167932 · Cited by 39
Cao, Q., Yu, C., Xue, R., Hsueh, W., Pan, P., Chen, Z., Wang, S., McNutt, M. A., & Gu, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.020 · Cited by 39
LAMP2 Microdeletions in Patients With Danon Disease
Zhao, Y. Y., Funke, B., Cripe, L. H., Vick, G. W., Mancini‐DiNardo, D., Peña, L. S., Kanter, R. J., Wong, B. L. Y., Westerfield, B. H., Varela, J. J., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.901785 · Cited by 39
Cardiomyocyte autophagy: metabolic profit and loss
Wang, Z. V., Ferdous, A., & Hill, J. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9350-y · Cited by 39
“LAMP2, a principal lysosomal membrane protein, is mutated in patients with Danon disease [26].”
BackgroundHendrikx, T., Bieghs, V., Walenbergh, S. M. A., van Gorp, P. J., Verheyen, F., Jeurissen, M. L. J., Steinbusch, M. M. F., Vaes, N., Binder, C. J., Koek, G. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078792 · Cited by 39
“In humans, a mutated Lamp2 gene results in Danon disease, characterized by intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells [40].”
BackgroundSAIJO, M., Takemura, G., Masahiko, K. O. D. A., Okada, H., Miyata, S., Ohno, Y., Kawasaki, M., Tsuchiya, K., Nishigaki, K., Minatoguchi, S., et al. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.700 · Cited by 39
Lobrinus, J. A., Schorderet, D. F., Payot, M., Jeanrenaud, X., Bottani, A., Superti‐Furga, A., Schläpfer, J., FROMER, M. A., & Jeannet, P. Y. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.12.007 · Cited by 39
“The disease is caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) [6], one of the proteins thought to protect the lysosomal membrane from proteolytic digestion and to act as a receptor for proteins to be imported into lysosomes [7].”
BackgroundA new congenital form of X-linked autophagic vacuolar myopathy
Yan, C., Tanaka, M., Sugie, K., Nobutoki, T., Woo, M., Murase, N., Higuchi, Y., Noguchi, S., Nonaka, I., Hayashi, Y. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000178979.19887.f5 · Cited by 39
Self-citationStaikou, ., Stamelos, M., & Stavroulakis, E. (2019) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2019.86278 · Cited by 38
“Deficiency of the LAMP-2B isoform causes lysosomal dysfunction with accumulation of autophagic material in the cardiac and skeletal muscles [13, 14].”
BackgroundXu, X., & Ren, J. T. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05638.x · Cited by 38
“As noted previously, defects in autophagy may contribute to the development of rare forms of cardiac diseases, such as Danon’s disease.(32) More interestingly, increased accumulation of autophagosomes has been observed in the cardiac tissues of patients suffering from ischaemia or pressure overload.”
BackgroundNovel LAMP-2 Mutation in a Family With Danon Disease Presenting With Hypertrophic Cardiomyopathy
Dougu, N., Joho, S., Shan, L., Shida, T., Matsuki, A., Uese, K., Hirono, K., Ichida, F., Tanaka, K., Nishino, I., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0241 · Cited by 38
Self-citationWei, X., Zhao, L., Xie, J., Liu, Y., Du, Z., Zhong, X., Ye, W., Wang, Y., Chen, Y., Lu, M., et al. (2021) · Radiology · doi:10.1148/radiol.2021203996 · Cited by 38
Chen, H. H., Khatun, Z., Lan, W., Mekkaoui, C., Patel, D., Kim, S. J. W., Boukhalfa, A., Enoma, E., Lin, M. S., Chen, Y. I., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00904-3 · Cited by 38
“, n = 3) and (4) starvation plus re-feeding (n = 3).”
Mitochondrial tRNA gene mutations in patients having mitochondrial disease with lactic acidosis
Ueki, I., Koga, Y., Povalko, N., Akita, Y., Nishioka, J., Yatsuga, S., Fukiyama, R., & Matsuishi, T. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.10.003 · Cited by 38
Self-citationPlatt, F. M., & Walkley, S. U. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0002 · Cited by 40
Lysosomal Storage Diseases-Regulating Neurodegeneration
Onyenwoke, R. U., & Brenman, J. E. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25475 · Cited by 37
Li, S., Liu, C., Gu, L., Wang, L., Shang, Y., Liu, Q., Wan, J., Shi, J. Y., Wang, F., Xu, Z., et al. (2016) · Open Biology · doi:10.1098/rsob.160177 · Cited by 37
Guan, R., Li, Z., Dai, X., Zou, W., Yu, X., Liu, H., Chen, Q., Teng, W., Liu, P., Liu, X., et al. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12131 · Cited by 37
Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease
Pang, S., Chen, D., Zhang, A., Qin, X., & Yan, B. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.044 · Cited by 38
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene
Musumeci, O., Rodolico, C., Nishino, I., Guardo, G. D., Migliorato, A., Aguennouz, M., Mazzeo, A. T., Messina, C., Vita, G., & Toscano, A. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2005.02.008 · Cited by 37
“Since the identification of LAMP-2 gene as the causative gene of Danon disease, few new cases have been reported in the literature [3,8,9].”
BackgroundMethodSelf-citationDias, C., Sincan, M., Cherukuri, P. F., Rupps, R., Huang, Y., Briemberg, H., Selby, K. A., Mullikin, J. C., Markello, T. C., Adams, D. R., et al. (2012) · Human Mutation · doi:10.1002/humu.22032 · Cited by 36
Ovics, P., Regev, D., Baskin, P., Davidor, M., Shemer, Y., Neeman-Egozi, S., Ben‐Haim, Y., & Binah, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197320 · Cited by 36
“Metabolic cardiomyopathies are also caused by mutations affecting metabolic enzymes such as PRKAG2 and LAMP2 [291,292].”
BackgroundInfluentialTakahashi, M., Yamamoto, A., Takano, K., Sudo, A., Wada, T., Goto, Y., Nishino, I., & Saitoh, S. (2002) · Annals of Neurology · doi:10.1002/ana.10235 · Cited by 37
Self-citationFu, L., Luo, S., Cai, S., Hong, W., Guo, Y., Wu, J., Liu, T., Zhao, C., Li, F., Huang, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.06.037 · Cited by 36
Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)
Yardeni, M., Weisman, O., Mandel, H., Weinberger, R., Quarta, G., Salazar‐Mendiguchía, J., García‐Pavía, P., Lobato‐Rodríguez, M. J., Simon, L. F., Dov, F., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38320 · Cited by 36
Small-Vessel Vasculopathy Due to Aberrant Autophagy in LAMP-2 Deficiency
Nguyen, H. T., Noguchi, S., Sugie, K., Matsuo, Y., Nguyen, C. T. H., Koito, H., Shiojima, I., Nishino, I., & Tsukaguchi, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-21602-8 · Cited by 36
“This notion is supported by the following observations in our study: (1) accumulation of damaged and superfluous mitochondria in VSMC, (2) biochemical increase in ROS, (3) enhanced mitochondrial respiration, (4) active proliferation, and (5) histologically proven medial hypertrophy (Fig.”
ResultSelf-citationPeng, Y., Tao, Y., Liu, L., Zhang, J., & Wei, B. (2023) · Aging and Disease · doi:10.14336/ad.2023.0823-4 · Cited by 35
“Defects in autophagic flux were initially observed in inherited cardiovascular diseases, including Danon and Pompe diseases [26-28].”
BackgroundDegradation systems in heart failure
Nishida, K., Yamaguchi, O., & Otsu, K. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.004 · Cited by 35
“LAMP2-deficient mice replicate the symptoms found in Danon patients with the accumulation of autophagic vacuoles in many tissues, including heart and skeletal muscles [98,99].”
BackgroundThe fine line between lifespan extension and shortening in response to caloric restriction
Szafranski, K., & Mekhail, K. (2014) · Nucleus · doi:10.4161/nucl.27929 · Cited by 35
“One possibility may be that activating autophagy when autophagic vesicles cannot fuse with lysosomes such as in Danon disease would be deleterious as this leads to an accumulation of non-functional autophagic vesicles.(105) In fact, aberrant autophagy genes are also linked to several other diseases including cancer (o…”
BackgroundKain, R., & Rees, A. J. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835b4f8f · Cited by 35
“This is especially true for LAMP-2 and is illustrated by the high death rate in LAMP-2 deficient mice and the development of severe cardiac and muscle disease in the context of ubiquitous abnormalities of lysosome function in survivors [26] – a phenotype identical to Danon disease, a genetic LAMP-2 deficiency in man […”
BackgroundDanon Disease as a Cause of Autophagic Vacuolar Myopathy
Zhao, Y. Y., & Vatta, M. (2007) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2007.00132.x · Cited by 35
Regulation of Autophagy by Metabolic and Stress Signaling Pathways in the Heart
Lee, Y., Lee, H.-Y., & Gustafsson, Å. B. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318256cdd0 · Cited by 35
“For instance, Danon disease is a fatal cardiomyopathy caused by a defect in the fusion between autophagosomes and lysosomes that leads to an accumulation of autophagosomes in the myocytes.(6,7) Also, cardiac specific deletion of the autophagy-related gene 5 (Atg5), a critical autophagy protein, in the adult heart lead…”
BackgroundKuech, E., Brogden, G., & Naim, H. Y. (2016) · Biochimie · doi:10.1016/j.biochi.2016.09.011 · Cited by 35
“Examples are activator proteins (saposins) required for sphingolipid hydrolysis [8], integral membrane proteins, like the lysosome-associated membrane protein-2 (LAMP2) affected in Danon disease [9], protective protein/cathepsin A affected in galactosialidosis [10] or modifier proteins like the Ca-formylglycinegenerat…”
BackgroundCSF lamp2 concentrations are decreased in female Parkinson’s disease patients with LRRK2 mutations
Klaver, A. C., Coffey, M. P., Aasly, J. O., & Loeffler, D. A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.016 · Cited by 35
The Glycogen Storage Diseases and Related Disorders
Laforêt, P., Weinstein, D. A., & Smit, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_6 · Cited by 35
Regulation of lysosomes in skeletal muscle during exercise, disuse and aging
Moradi, N., Sanfrancesco, V. C., Champsi, S., & Hood, D. A. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.028 · Cited by 35
Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)
Samad, F., Jain, R., Jan, M. F., Sulemanjee, N., Menaria, P., Kalvin, L., Bush, M. L., Jahangir, A., Khandheria, B. K., & Tajik, A. J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.031 · Cited by 34
Oxidative Stress and Cell Death in Cardiovascular Disease
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00014-7 · Cited by 34
Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies
Pieroni, M., Ciabatti, M., Saletti, E., Tavanti, V., Santangeli, P., Martinese, L., Liïstro, F., Olivotto, I., & Bolognese, L. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01778-2 · Cited by 34
Boudina, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320004 · Cited by 34
Epigenetic drugs in the treatment of skeletal muscle atrophy
Guasconi, V., & Puri, P. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282fa1810 · Cited by 34
Cardiac Complications of Childhood Myopathies
Muntoni, F. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180030301 · Cited by 34
Multiple recycling routes: Canonical vs. non-canonical mitophagy in the heart
Moyzis, A. G., & Gustafsson, Å. B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.034 · Cited by 34
Treatment options for lysosomal storage disorders: developing insights
Gelder, C. M. V., Vollebregt, A. A. M., Plug, I., van der Ploeg, A. T., & Reuser, A. J. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.729039 · Cited by 33
“Interestingly, LAMP-2 deficiency hampers the fusion of autophagosomes and lysosomes, and is characterized by extralysosomal vesicular storage of glycogen in the heart (Danon disease) [10].”
BackgroundAutophagic dysfunction of β cell dysfunction in type 2 diabetes, a double-edged sword
Ding, Y., GangYi, Y., & Qi-nan, W. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.003 · Cited by 34
Sex-biased autophagy as a potential mechanism mediating sex differences in ischemic stroke outcome
Moruno-Manchon, J., Noh, B., & McCullough, L. D. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.340406 · Cited by 33
“Nishino et al., 2000; Spinazzi et al., 2008; Maron et al., 2009; Rothaug et al., 2015 ATP6AP2: ATPase H+ transporting accessory protein-2; HDAC6: histone deacetylase 6; LAMP2: lysosomal associated membrane protein-2; RAB39: Ras-related GTPbinding protein rab-39B; WDR45/WIPI4: WD repeat domain-45 or…”
BackgroundConte, F., Sam, J.-E. S. J. B. , Lefeber, D. J., & Passier, R. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108632 · Cited by 33
“Two specific LAMP2 mutations have been associated with prominent hypertrophy and electrophysiological abnormalities [157,158].”
BackgroundCell death signalling mechanisms in heart failure.
Mughal, W., & Kirshenbaum, L. A. (2011) · PubMed Central · Cited by 33
Autophagy in Cardiac Plasticity and Disease
Hill, J. A. (2011) · Pediatric Cardiology · doi:10.1007/s00246-010-9883-6 · Cited by 33
Xing, R., Liu, D., Cheng, X., Tian, X., Yan, C., & Han, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.092 · Cited by 33
Pasqua, T., Rocca, C., Giglio, A., & Angelone, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040721 · Cited by 33
Genetics and metabolic cardiomyopathies
Wicks, E. C., & Elliot, P. M. (2012) · Herz · doi:10.1007/s00059-012-3659-0 · Cited by 33
Lysosomal Chat Maintains the Balance
Massey, A. C., Kaushik, S., & Cuervo, A. M. (2006) · Autophagy · doi:10.4161/auto.3090 · Cited by 32
Atg2, Atg9 and Atg18 in mitochondrial integrity, cardiac function and healthspan in Drosophila
Xu, P., Damschroder, D., Zhang, M., Ryall, K. A., Adler, P. N., Saucerman, J. J., Wessells, R. J., & Yan, Z. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.12.006 · Cited by 32
Wen, B., Tang, S., Lv, X., Li, D., Xu, J., Olsen, R. K. J., Zhao, Y., Li, W., Wang, T., Shao, K., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab308 · Cited by 32
The Biology of Lysosomes: From Order to Disorder
Amaral, O., Martins, M. M., Oliveira, A. R., Duarte, A. J., Mondragão-Rodrigues, I., & Macedo, M. F. (2023) · Biomedicines · doi:10.3390/biomedicines11010213 · Cited by 32
Late adult‐onset of X‐linked myopathy with excessive autophagy
Crockett, C. D., Ruggieri, A., Gujrati, M., Zallek, C. M., Ramachandran, N., Minassian, B. A., & Moore, S. A. (2014) · Muscle & Nerve · doi:10.1002/mus.24197 · Cited by 32
“pathway via facilitation of autophagosome–lysosome fusion.(2,8,9) Danon disease, caused by muta-”
BackgroundSugie, K., Yoshizawa, H., Onoue, K., Nakanishi, Y., Eura, N., Ogawa, M., Nakano, T., Sakaguchi, Y., Hayashi, Y. K., Kishimoto, T., et al. (2016) · Neuropathology · doi:10.1111/neup.12307 · Cited by 32
“Female patients with Danon disease have a relatively milder and later-onset clinical phenotype than male patients.(1,2) As the underlying reason, we suggest that haploinsufficiency along with skewed X-chromosome inactivation may be clinically significant determinants of phenotype in heterozygous female patients with D…”
BackgroundMethodSelf-citationZhang, X., Li, L., Zhang, Q., Wei, Q., Lin, J., Jia, J., Zhang, J., Yan, T., Lv, Y., Jiang, X., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00191 · Cited by 32
Autophagy and Ubiquitination in Cardiovascular Diseases
Martins‐Marques, T., Ribeiro‐Rodrigues, T., Pereira, P., Codogno, P., & Girão, H. (2015) · DNA and Cell Biology · doi:10.1089/dna.2014.2765 · Cited by 32
“Additionally, in Danon disease patients, a condition clinically characterized by cardiomyopathy, LAMP-2 deficiency emerges as a primary cause (Nishino et al., 2000).”
The physiology of the retinal pigment epithelium in Danon disease
Thompson, D. A., Constable, P. A., Liasis, A., Walters, B., & Esteban, M. T. (2016) · Retina · doi:10.1097/iae.0000000000000736 · Cited by 31
“Danon disease(1) (OMIM 300257) is a rare, X-linked, dominant lysosomal storage disease, caused by mutations in a gene that encodes lysosomeassociated membrane protein-2 (LAMP-2) (Xq24).(2) LAMP-2 is involved in the fusion of autophagic vacuoles with endosomes and lysosomes at the limiting membrane of lysosomes.”
BackgroundZidovudine-Mediated Autophagy Inhibition Enhances Mitochondrial Toxicity in Muscle Cells
Lin, H., Stankov, M. V., Hegermann, J., Budida, R., Panayotova‐Dimitrova, D., Schmidt, R. E., & Behrens, G. M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-18 · Cited by 31
“For example, Danon disease, a genetic disease characterized by cardiomyopathy and myopathy, is related to a mutation in the lysosomal protein lysosome-associated membrane protein 2 (LAMP-2) and is associated with the profound accumulation of autophagosomes in the muscles of LAMP-2-deficient mice and patients potential…”
BackgroundNanoparticle-Mediated Therapeutic Application for Modulation of Lysosomal Ion Channels and Functions
Lee, D., & Hong, J. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030217 · Cited by 31
“In addition, deficiency of several lysosomal membrane proteins trigger various diseases such as the Danon disease (lysosome associated membrane proteins, LAMP-2) [24], malignant infantile osteopetrosis (the chloride channel 7, CLC-7) [25], and actin myoclonus-renal failure syndrome (lysosomal integral membrane protein…”
BackgroundPre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
Favret, J., Weinstock, N. I., Feltri, M. L., & Shin, D. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00057 · Cited by 31
Roles of Stress Response in Autophagy Processes and Aging-Related Diseases
Watanabe, Y., Taguchi, K., & Tanaka, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813804 · Cited by 31
Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion
Kassan, A., Pham, U., Nguyen, Q., Reichelt, M. E., Cho, E., Patel, P. M., Roth, D. M., Head, B. P., & Patel, H. H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00147.2016 · Cited by 31
“Such a dichotomy, where critical activation or loss of autophagy regulates cardiac stress adaptation, suggests that autophagy may be a homeostatic process necessary to maintain heart function during stress (94), and potential augmentation of the autophagic process may lead to protection and enhanced stress adaptation…”
BackgroundMani, K. M., Javaheri, A., & Diwan, A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180005 · Cited by 31
Autophagy and Cell Death in Caenorhabditis elegans
Tavernarakis, N., & Samara, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783378770 · Cited by 31
“LAMP2 deficiency has been associated with the development of cardiac and skeletal myopathies during Danon’s disease [102].”
BackgroundProtein isoform-centric therapeutics: expanding targets and increasing specificity
Kjer-Hansen, P., Phan, T. G., & Weatheritt, R. J. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01025-z · Cited by 30
“Accordingly, transient, developmental stage-specific introduction of the missing protein isoform is appropriate.”
Autophagy: Can it become a potential therapeutic target? (Review)
Naomoto (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000369 · Cited by 30
“The failure of autophagosome to fuse with lysosome leads to large amount of autophagosomes accumulating in the muscles of LAMP-2deficient mice and patients.”
BackgroundAdvances in the treatment of lysosomal storage disease
Wraith, J. E. (2001) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201001165 · Cited by 30
Pathogenic cascades and brain dysfunction
Walkley, S. U. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0012 · Cited by 30
Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
Ge, F., Wang, Z., & Xi, J. (2019) · Cells · doi:10.3390/cells9010009 · Cited by 29
“hiPSC-CMs can be used to model several heart diseases, including Duchenne muscular dystrophy [10], Leopard syndrome [11], long QT syndrome [12], Timothy syndrome [13], Fabry disease [14], Danon disease [15], and familial hypertrophic cardiomyopathy [16].”
MethodSingh, S. R., Meyer-Jens, M., Alizoti, E., Bacon, W. C., Davis, G., Osińska, H. E., Gulick, J. M., Reischmann, S., Orthey, E., McLendon, P. M., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1856493 · Cited by 29
Xie, F., Liu, W., Feng, F., Li, X., Yang, L., Lv, D., Qin, X., Li, L., & Chen, L. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu046 · Cited by 29
“In the heart, the level of autophagy is altered not only in response to stress such as ischemia/reperfusion [37–39], but also to stress triggered by CVDs such as cardiac hypertrophy [40] and heart failure [41,42].”
BackgroundLAMP-2 mediates oxidative stress-dependent cell death in Zn 2+ -treated lung epithelium cells
Qin, X., Zhang, J., Wang, B., Xu, G., & Zou, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.030 · Cited by 29
Ultrastructural aspects of vacuolar degeneration of cardiomyocytes in human endomyocardial biopsies
Takemura, G., Kanamori, H., Okada, H., Tsujimoto, A., Miyazaki, N., Takada, C., Hotta, Y., Takatsu, Y., Fujiwara, T., & Fujiwara, H. (2017) · Cardiovascular Pathology · doi:10.1016/j.carpath.2017.06.012 · Cited by 29
Farah, B. L., Yen, P. M., & Koeberl, D. D. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.11.005 · Cited by 29
“Patients with Danon disease harbour mutations in LAMP2, an essential lysosomal membrane gene that affects both types of autophagy [120].”
BackgroundCardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum
Aksu, T., Çolak, A., & Tüfekçioğlu, O. (2012) · Case Reports in Medicine · doi:10.1155/2012/764286 · Cited by 29
“Although Danon’s disease, an X-linked recessive lysosomal glycogen storage disease, progresses with hypertrophic cardiomyopathy and neurological involvement [12], there was no case of hypertrophic cardiomyopathy related to GSD IV in the literature in our knowledge.”
BackgroundKwon, I., Lee, Y., Cosío-Lima, L., Cho, J., & Yeom, D.-C. (2015) · Physical Activity and Nutrition · doi:10.5717/jenb.2015.15090710 · Cited by 29
“Supporting our results, other studies have also reported that LAMP-2 deficiency can be a potent inducer of myopathies evidenced in human Danon’s disease and LAMP-2 deficient mice [62,63].”
ResultBi, J., Sun, Y., Guo, M., Sun, X., sun, J., Jiang, R., Wang, N., & Huang, G. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03771-5 · Cited by 27
“This disease significantly affects the health of the heart and muscles, further highlighting the importance of LAMP-2 in the repair and regeneration of cardiac cells [170].”
Greiner-Tollersrud, O. K., & Berg, T. (2007) · Springer eBooks · doi:10.1007/0-387-28957-7_6 · Cited by 28
Mehmood, T., Schneider‐Anthony, A., Sibille, J., Pereira, P. M., Pannetier, S., Ammar, M. R., Dembélé, D., Thibault-Carpentier, C., Rouach, N., & Hanauer, A. (2010) · Human Genetics · doi:10.1007/s00439-010-0918-0 · Cited by 28
“Strikingly, two of the genes with altered expression in Rsk2-KO hippocampi, Lamp2 and Cul4b, have previously been associated with syndromic forms of X-linked mental retardation (Nishino et al. 2000; Zou et al. 2007).”
BackgroundMijaljica, D., Prescott, M., & Devenish, R. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-756-3_5 · Cited by 28
Autophagy, innate immunity, and cardiac disease
Santovito, D., Steffens, S., Barachini, S., & Madonna, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1149409 · Cited by 27
“In line with these findings, Lamp2-deficient mice displayed increased autophagic vacuole accumulation and could not degrade proteins, thereby promoting cardiomyopathy (Nishino et al., 2000; Tanaka et al., 2000; Maron et al., 2009).”
BackgroundKandula, N., Kumar, S., Mandlem, V., Siddabathuni, A., Singh, S. K., & Kosuru, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7346699 · Cited by 27
“…involved in various metabolic functions such as lipid metabolism [e.g., acetyl-CoA carboxylase (ACC); 3-hydroxy-3-methyl-glutaryl-CoA 3 Oxidative Medicine and Cellular Longevity clinical manifestations of Danon disease (autophagic vacuolar myopathy) resulting due to the mutation in LAMP-2 [63, 64].”
Métrailler, S., Schorderet, D. F., & Cottet, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.12.019 · Cited by 27
Majer, F., Vlášková, H., Król, L., Kalina, T., Kubánek, M., Stolnaja, L., Dvořáková, L., Elleder, M., & Sikora, J. (2012) · Gene · doi:10.1016/j.gene.2012.02.004 · Cited by 27
“In agreement with the report by Nishino et al. (2000) on the LAMP2B”
ResultIdentification of Two Novel LAMP2 Gene Mutations in Danon Disease
Csányi, B., Popoiu, A., Haţegan, L., Hegedüs, Z., Nagy, V., Rácz, K., Högye, M., Sághy, L., Iványi, B., Csanády, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.071 · Cited by 27
“Blood creatine kinase (CK) levels are usually elevated (ranging from 300 to 3000 U/L).(2) Danon disease is caused by a primary deficiency of lysosome-associated membrane protein-2 (LAMP-2), whose gene (LAMP2) maps to chromosome region Xq24.”
BackgroundMori, M., Bailey, L. A., Estrada, J. C., Rehder, C. W., Li, J. S., Rogers, J. G., Bali, D. S., Buckley, A. F., & Kishnani, P. S. (2016) · JIMD Reports · doi:10.1007/8904_2016_563 · Cited by 27
“Cardiomyopathy associated with glycogen storage includes PRKAG2-associated glycogen storage (Arad et al. 2002), Danon disease (Nishino et al. 2000), infantile Pompe disease (GSD II) (Kishnani et al. 2006), GSD III (Kishnani Communicated by: Marc Patterson M. Mori (*) : L.A. Bailey :D.S. Bali : P.S.…”
BackgroundGenomic Insights into Cardiomyopathies: A Comparative Cross-Species Review
Simpson, S., Rutland, P., & Rutland, C. S. (2017) · Veterinary Sciences · doi:10.3390/vetsci4010019 · Cited by 27
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.